2015 Articles
The Need for Vigilance in the Marketing of Genomic Tests in Psychiatry
Recently, several for-profit companies have been developing and marketing genetic tests to psychiatrists, yet the clinical utility of these is not always clear, posing several concerns. Important genomic research is continuing, and genomic tests potentially can help with both the diagnosis and treatment of many patients. Yet it is important that clinicians be aware of potential limitations of tests that may be marketed to them.
Subjects
Files
-
Klitzman_The need for vigilance in the marketing of genomic tests in psychiatry.pdf
application/pdf
22.2 KB
Download File
Also Published In
- Title
- The Journal of Nervous and Mental Disease
- DOI
- https://doi.org/10.1097/NMD.0000000000000372
More About This Work
- Academic Units
- Psychiatry
- Published Here
- July 27, 2020